Given the intertwined metabolic and endocrine abnormalities in PCOS, along with the elevated risk of NAFLD in this population, there is a compelling need to explore the role of SPX in these conditions. The gene discussed is SPX; the disease is metabolic dysfunction-associated steatotic liver disease.